The Biochips Market is expected to exceed more than US$ 30 Billion by 2028 at a CAGR of 18%.
Biochip could be a miniaturized medical device utilized in molecular laboratories to hold out many organic chemistry reactions at the same time. It will rapidly screen variety of biological analytes for an array of applications like disease identification and detection of venturous biological agents in an exceedingly system. It’s designed on the premise of microarray and microfluidic technologies, among that digital microfluid chip is very efficient, and has gained vital quality within the biochemical field. Increase in prevalence of cancer, immunological disorders, and infective agent infections majorly drives the expansion of the worldwide biochips market. Alternative factors that boost the market growth embody rise in geriatric population, increase in range of chip applications, and high adoption of customized medications. However, factors like high value of chip and lack of information concerning it majorly in rising nations hamper the market growth. Conversely, rise in R&D investment in addition as government funding and high potential in untapped markets in rising economies are expected to produce lucrative growth opportunities for the market.
Global Biochips Market is segmented based on the deployment model as Cloud and On-premise. The report segments global Biochips Market based on the basis of product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. Based on end-user it covers biotechnology & pharmaceutical companies, hospitals & diagnostics centres, academic & research institutes, and others. Based on application it covers drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others. Global Biochips Market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Biochips Market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global Biochips Market share consists of several players including bioMérieux SA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.
The Biochips Market has been segmented as below:
Biochips Market, By Product
Biochips Market, By Application
Biochips Market, By End-User
Biochips Market, By Region
The report covers:
Report scope:
The global Biochips Market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include bioMérieux SA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Biochips Market, By Product
5.1. Key Points
5.2. DNA Chip
5.3. Protein Chip
5.4. Lab-on-a-chip
5.5. Others
6. Biochips Market, By Application
6.1. Key Points
6.2. Drug Discovery & Development
6.3. Disease Diagnostics
6.4. Genomics
6.5. Proteomics
6.6. Agriculture
6.7. Others
7. Biochips Market, By End-User
7.1. Key Points
7.2. Biotechnology & Pharmaceutical Companies
7.3. Hospitals & Diagnostics Centers
7.4. Academic & Research Institutes
7.5. Others
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. bioMrieux S.A.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Bio-Rad Laboratories, Inc.
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. F. Hoffmann-La Roche Ltd.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Fluidigm Corporation
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Illumina, Inc.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. HORIBA, Ltd.
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. PerkinElmer, Inc.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. QIAGEN N.V.
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
The Biochips Market has been segmented as below:
Biochips Market, By Product
Biochips Market, By Application
Biochips Market, By End-User
Biochips Market, By Region
